CD44 and breast carcinoma: The aim of our study was to identify the CD44+/CD24− cell population in surgical specimens of primary breast carcinomas using immunohistochemical methods, with the goal of correlating the amount and distribution of CD44+/CD24− cells with clinicopathological features.